These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 8322261

  • 1. Fibrin and cancer.
    Costantini V, Zacharski LR.
    Thromb Haemost; 1993 May 03; 69(5):406-14. PubMed ID: 8322261
    [No Abstract] [Full Text] [Related]

  • 2. [Intravascular blood coagulation and its role in malignant neoplasms].
    Pavlovskiĭ DP.
    Vopr Onkol; 1981 May 03; 27(7):96-103. PubMed ID: 7023043
    [No Abstract] [Full Text] [Related]

  • 3. Hemostatic factors in tumor biology.
    Palumbo JS, Degen JL.
    J Pediatr Hematol Oncol; 2000 May 03; 22(3):281-7. PubMed ID: 10864065
    [No Abstract] [Full Text] [Related]

  • 4. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
    Gieseler F, Lühr I, Kunze T, Mundhenke C, Maass N, Erhart T, Denker M, Beckmann D, Tiemann M, Schulte C, Dohrmann P, Cavaillé F, Godeau F, Gespach C.
    Thromb Haemost; 2007 Jun 03; 97(6):1023-30. PubMed ID: 17549306
    [Abstract] [Full Text] [Related]

  • 5. [Cancer procoagulant--biochemical characteristics and the influence on the development of neoplastic disease].
    Kamocka M, Mielicki WP.
    Postepy Biochem; 2003 Jun 03; 49(3):168-74. PubMed ID: 15083609
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Plasma clotting system in neoplastic diseases].
    Brajerski W.
    Pol Tyg Lek; 1976 Jul 05; 31(27):1169-72. PubMed ID: 781641
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Coagulation in the context of cancer].
    Sánchez-Fayos J.
    Rev Clin Esp; 1983 May 15; 169(3):153-6. PubMed ID: 6193569
    [No Abstract] [Full Text] [Related]

  • 12. Fibrinogen and the fibrinogenopathies.
    Morse EE.
    Ann Clin Lab Sci (1971); 1971 May 15; 1(2):155-61. PubMed ID: 4949447
    [No Abstract] [Full Text] [Related]

  • 13. Overview of the postulated mechanisms linking cancer and thrombosis.
    ten Cate H, Falanga A.
    Pathophysiol Haemost Thromb; 2008 May 15; 36(3-4):122-30. PubMed ID: 19176985
    [Abstract] [Full Text] [Related]

  • 14. Cancer cell procoagulants and their implications.
    Gordon SG.
    Hematol Oncol Clin North Am; 1992 Dec 15; 6(6):1359-74. PubMed ID: 1452517
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cancer procoagulant--CP.
    Rucińska M, Gacko M, Skrzydlewski Z.
    Rocz Akad Med Bialymst; 1997 Dec 15; 42 Suppl 1():110-7. PubMed ID: 9337529
    [Abstract] [Full Text] [Related]

  • 17. Fibrinogen Amsterdam, another hereditary abnormality of fibrinogen.
    Janssen CL, Vreeken J.
    Br J Haematol; 1971 Mar 15; 20(3):287-98. PubMed ID: 4101579
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Coagulation disorders without hemorrhagic diathesis due to delayed aggregration of fibrin molecules].
    von Felten A, Duckert F, Frick P.
    Schweiz Med Wochenschr; 1965 Oct 23; 95(43):1453-6. PubMed ID: 5880932
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.